menu search

Continued strong cresemba® (isavuconazole) sales by astellas in the u.s. trigger chf 20 million sales milestone payment to basilea

Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial a...

January 9, 2023, 6:29 am


Search within

Pages Search Results: